Associate
During law school, Megan completed a certificate program focused on advising biology Ph.D. students on intellectual property matters, including patentability, freedom-to-operate, and obtaining protection for their technologies. The program also involved analyzing the commercialization of the researchers' innovative technologies. Megan also worked as an analyst for an angel investing group that evaluates startup companies for investment potential, including the strength of their patent portfolios.
While completing her undergraduate degrees, Megan worked in a prosthetics and orthotics lab, which allowed her to gain experience with the fabrication of various medical devices. Megan manages the Drugs section of the firm's IP FDA blog, where she identifies topics for blog posts and assists in editing and coordinating the publication of these posts. She has used her knowledge of the Food & Drug Administration and Orange Book procedures to assist in client counseling regarding these topics.
Megan has a passion for pro bono work. While in law school, she worked with the Health Law Partnership, a branch of Atlanta Legal Aid that partners with impoverished families and children who are patients at Children's Healthcare of Atlanta. Her work with these families included addressing landlord/tenant issues, Supplemental Security Income (SSI), disability, and family law matters. As a summer associate at Finnegan, Megan wrote a brief to file with the U.S. Court of Appeals for Veterans Claims on behalf of an injured veteran. She continues to successfully represent injured veterans as an associate with the firm.
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
1:21-cv-01736, 1:23-cv-00554, D. Del., Judge Andrews
AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
1:18-cv-00664, D. Del., Judge Andrews
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
1:21-cv-00870, D. Del., Judge Hall
IP Health Blog
FDA Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds FDA Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds
February 24, 2023
At the PTAB Blog
Board Reaffirms that Assignor Estoppel Does Not Bar Assignor from Filing IPR Petition Board Reaffirms that Assignor Estoppel Does Not Bar Assignor from Filing IPR Petition
December 21, 2022
IP Health Blog
Smart Baby Monitors May Be Considered Medical Devices by FDA Smart Baby Monitors May Be Considered Medical Devices by FDA
June 16, 2022
Press Release
46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll 46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll
June 3, 2022
Media Mention
Litigators of the Week: Shout Out Litigators of the Week: Shout Out
October 22, 2021
The AmLaw Litigation DailyDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.